 IQVIA is one of my favorite investments thanks to it being one of the leading CROs with a broad array of services. IQVIA has over 10,000 customers including big pharma. I was concerned IQVIA was going to struggle following the pandemic, but they have continued to deliver strong financial marks and seem to expect significant growth in the coming years. 